First US clinical trial testing efficacy of delivering aerosolized chemotherapy
(City of Hope) City of Hope surgical researchers are the first in the nation to open a clinical trial that could one day become an effective way to deliver chemotherapy to abdominal cancer patients who currently have very few treatment options. Ovarian, uterine, gastric and colorectal cancers can be difficult to treat using traditional intravenous chemotherapy, especially when the tumors spread to a thin layer of tissue that lines the abdomen called the peritoneum. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 11, 2020 Category: Cancer & Oncology Source Type: news

Most women treated in New York City for gynecologic cancers
(NYU Langone Health / NYU School of Medicine) Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalized for or dying from COVID-19 due to their cancer, a new study shows. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 30, 2020 Category: International Medicine & Public Health Source Type: news

Why this Peninsula drug maker's stock soared 40% higher today
Shares of Myovant Sciences Ltd. soared as much as 55% Monday after the company this weekend unloaded fresh data around a drug for prostate cancer and said this morning that it is asking regulators to approve the same drug's use to treat women with uterine fibroids. The 214-employee company (NYSE: MYOV), with its main offices in Brisbane, said a late-stage prostate cancer study of its drug relugolix expanded on earlier findings, finding its once-a-day pill has a lower risk of heart problems compared… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 1, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Why this Peninsula drug maker's stock soared 40% higher today
Shares of Myovant Sciences Ltd. soared as much as 55% Monday after the company this weekend unloaded fresh data around a drug for prostate cancer and said this morning that it is asking regulators to approve the same drug's use to treat women with uterine fibroids. The 214-employee company (NYSE: MYOV), with its main offices in Brisbane, said a late-stage prostate cancer study of its drug relugolix expanded on earlier findings, finding its once-a-day pill has a lower risk of heart problems compared… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 1, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

Adavosertib Induces Tumor Shrinkage in 30% of Patients with Uterine Serous Carcinoma
A recent clinical trial ’s results found that a targeted drug known as adavosertib caused tumors in nearly 30% of patients examined with uterine serous carcinoma, a hard-to-treat form of uterine cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 29, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news

New targeted agent produces considerable responses in patients with uterine cancer
(Dana-Farber Cancer Institute) The DNA repair-blocking drug adavosertib shrinks tumors in nearly one-third of patients in clinical trial data to be shared at the Society for Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 23, 2020 Category: Cancer & Oncology Source Type: news

Gene signature found for poor response to standard chemotherapy in rare uterine cancer
(Medical College of Georgia at Augusta University) Women who don't survive a rare and aggressive uterine cancer called uterine serous carcinoma, have high expression of a group of 73 genes, a score scientists say can help identify these women and improve their outcome. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

Human uterus colonized by clones with cancer-driving mutations that arise early in life
(Wellcome Trust Sanger Institute) Many cells in the inner lining of the uterus carry 'cancer-driving' mutations that frequently arise early in life, report scientists from the Wellcome Sanger Institute, the University of Cambridge and their collaborators. The research team conducted whole-genome sequencing of healthy human endometrium, providing a comprehensive overview of the rates and patterns of DNA changes in this tissue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 22, 2020 Category: Cancer & Oncology Source Type: news

New, detailed molecular roadmap boosts fight against endometrial cancer
(DOE/Pacific Northwest National Laboratory) Scientists have taken an unprecedented look at the proteins involved in endometrial cancer, commonly known as uterine cancer. The study offers insights about how physicians might be able to better identify which patients will need aggressive treatment and which won't, and offers clues about why a common cancer treatment is not effective with some patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 13, 2020 Category: Cancer & Oncology Source Type: news

What Do You Do For Breast Milk Jaundice?
Discussion Almost all infants in the first few days of life have some elevation of their bilirubin because of the various physiologic changes they undergo in the transition to extra-uterine life. This is a common problem managed by many different inpatient and outpatient healthcare providers. This hyperbilirubinemia is usually unconjugated and resolves in the first 1-2 weeks of life. However, when it does not resolve, health care providers have 3 general paths to follow when considering a cause: inadequate breast milk intake, an underlying organic cause or breast milk jaundice. Inadequate breastfeeding is not uncommon and...
Source: PediatricEducation.org - February 3, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

With prostate cancer trial done, Peninsula drug maker will ask for FDA approval
Myovant Sciences also will seek FDA approval next year of a different version of the same drug to treat heavy menstrual bleeding in women with uterine fibroids. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 3, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

With prostate cancer trial done, Peninsula drug maker will ask for FDA approval
Myovant Sciences also will seek FDA approval next year of a different version of the same drug to treat heavy menstrual bleeding in women with uterine fibroids. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 3, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

The Prognosis of Stage IA Mixed Endometrial Carcinoma The Prognosis of Stage IA Mixed Endometrial Carcinoma
A study determines that the serous subtype may be associated with a poor prognosisin in uterine cancer.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 31, 2019 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

AI can accurately predict uterine fibroid embolization outcomes
An artificial intelligence (AI) algorithm's analysis of MRI exams performed...Read more on AuntMinnie.comRelated Reading: SIR: UFE bests myomectomy for fibroid treatment Artificial intelligence for MRI distinguishes uterine cancer from fibroids Study finds low reintervention rate for UAE of fibroids Further intervention rates vary after fibroid removal Online patient info about UAE could be better (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 13, 2019 Category: Radiology Source Type: news

Linkage between evolution of pregnancy and cancer spread explained
In humans, the placenta invades the wall of the uterus in much the same way that cancer cells invade the surrounding tissues at the outset of metastasis. (Source: Yale Science and Health News)
Source: Yale Science and Health News - November 26, 2019 Category: Universities & Medical Training Source Type: news

CVD mortality much higher among cancer patients
CVD mortality highest in first year from diagnosis; and also much higher for bladder, larynx, prostate and uterine cancers Related items fromOnMedica Exercise essential for people diagnosed with cancer NHS must improve access to screening to save lives Metastatic breast cancer goes undiagnosed for too long Cancer strategies failed to improve one-year survival Cancer mortality cut by a third in young people (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 26, 2019 Category: UK Health Source Type: news

UCLA Mattel Children ’s Hospital helps kids trick-or-treat
Three-year-old Harmon Jones strutted in his “Black Panther” costume as he prowled the UCLA Mattel Children’s Hospital hallways and main lobby for treats. After watching a special magic show and playing some tunes led by music therapists, he wanted some Halloween candy.“My favorite part is the lollipops!” Harmon said. “I like to share them with my mommy and daddy!”For Heather and Shaw Jones, Harmon ’s parents, holidays bring some sense of the normal and community. Last summer, Harmon was diagnosed with rhabdomyosarcoma, a rare cancer that forms in soft tissue — specifica...
Source: UCLA Newsroom: Health Sciences - November 1, 2019 Category: Universities & Medical Training Source Type: news

Study: Women Who Use IUDs May Have Lower Risk Of Ovarian Cancer
BOSTON (CBS) – Not only do IUDs prevent pregnancy, they may lower the risk of ovarian cancer in the women who use them. Researchers at the University of Colorado reviewed a dozen prior studies involving several thousand patients and found that women who used IUDs were up to 32-percent less likely than other women to develop ovarian cancer. It’s not clear why, but scientists found that the hormones released by some IUDs may block estrogen which help ovarian tumor glow. And having a foreign body in the uterus may trigger the immune system to help fight cancer. Birth control pills have also been linked to a lower ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 17, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch News Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall IUD ovarian cancer Source Type: news

Hysterectomy Technique Tied to Poorer Uterine Cancer Outcomes
Uncontained uterine power morcellation tied to higher mortality in women with undetected uterine cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 7, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Surgery, Journal, Source Type: news

Hysterectomy Technique Tied to Poorer Uterine Cancer Outcomes
MONDAY, Oct. 7, 2019 -- Uncontained power morcellation is associated with a higher mortality risk in women with occult uterine sarcoma, especially in those with occult leiomyosarcoma, according to a study published online Sept. 16 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 7, 2019 Category: Pharmaceuticals Source Type: news

Unexpected Uterine Cancer: Power Morcellation and Mortality
A study recently published in the Journal of Clinical Oncology reported on the association between power morcellation and mortality in women with unexpected uterine cancer who were undergoing a hysterectomy or myomectomy. (Source: CancerNetwork)
Source: CancerNetwork - October 1, 2019 Category: Cancer & Oncology Authors: Leanne Marcello, MS Source Type: news

Hysterectomy Procedure Tied to Worse Cancer Outcomes
THURSDAY, Sept. 19, 2019 -- Women who must have their uterus removed should be wary of a procedure called uncontained uterine power morcellation, Yale University researchers warn. This once common surgical option for hysterectomy or myomectomy... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 19, 2019 Category: General Medicine Source Type: news

Once-common hysterectomy technique linked to worse uterine cancer outcomes
Uncontained uterine power morcellation, a laparoscopic hysterectomy technique, may worsen outcomes for women who have undiagnosed uterine cancer. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 16, 2019 Category: Universities & Medical Training Source Type: news

Women Who Use IUDs May Be At Lower Risk For Ovarian Cancer, Study Finds
BOSTON (CBS) – Nearly 14,000 American women will die from ovarian cancer this year, but a new study from the UCHealth University of Colorado Hospital finds that women who use IUDs may be at lower risk. The symptoms of ovarian cancer can be mild or vague and there is no reliable screening test, so the diagnosis often isn’t made until it’s pretty advanced. But a new study of thousands of women around the world found that women who use intrauterine devices, or IUDs, for contraception may be 15-32% less likely to develop ovarian cancer. It’s not clear for how long they need to use one or why they may be...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 11, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall HealthWatch IUD Source Type: news

Mayo Clinic Minute: 3 things women should know about gynecologic cancer
Cancer of a woman's reproductive organs is referred to as "gynecologic cancer." Dr. Amanika Kumar, a Mayo Clinic OB-GYN, says there are many forms of gynecologic cancer: endometrial or uterine, ovarian, vulvar, cervical, and vaginal. Watch: The Mayo Clinic Minute https://youtu.be/G6371uKfois Journalists: Broadcast-quality video pkg (0:58) is in the downloads at the end of the post. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 9, 2019 Category: Databases & Libraries Source Type: news

Two Genes Conspire in Endometriosis and Cancer to Help Cells Migrate
The genes promote the migration of endothelial cells outside of the uterus, a characteristic of both endometriosis and endometrial cancers, a study of mice and human tissue finds. (Source: The Scientist)
Source: The Scientist - August 9, 2019 Category: Science Tags: News & Opinion Source Type: news

Podcast: Use of computer or robotic technology to assist surgeons in performing gynaecological surgery
In conclusion, low-certainty evidence for hysterectomy and sacrocolpopexy operations suggests that complication rates for robot-assisted surgery might be similar to those for conventional laparoscopic surgery. Things are more uncertain for gynaecological cancer, where we found no comparative evidence on cancer recurrence or survival after the surgery. As robot-assisted surgery depends on the skill and experience of the surgeon and is expensive, evaluating its effectiveness and safety continues to present a challenge; but this needs to be met if we are to have reliable evidence on its potential benefits and harms.Read the C...
Source: Cochrane News and Events - August 9, 2019 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Molecular analysis could improve the early detection and prevention of endometrial cancer
(IDIBELL-Bellvitge Biomedical Research Institute) Researchers from IDIBELL and ICO lead the proposal to evaluate genomic analyzes in cervical cytologies to improve the detection of cancer of the uterine cavity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 17, 2019 Category: Cancer & Oncology Source Type: news

Radiation plus chemotherapy doesn't improve endometrial cancer recurrence-free survival
(Northwestern University) The standard of care for women with stage III/IVA endometrial cancer following surgery has been chemotherapy and radiation to prevent recurrence. But in a surprising new finding, radiation combined with chemotherapy did not increase recurrence-free survival in these women, reports a National Cancer Institute-sponsored study. Chemotherapy alone should now be the standard of care for stage III uterine cancer, the lead author said. This is the first study comparing the combined regimen to chemotherapy alone. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 12, 2019 Category: Cancer & Oncology Source Type: news

NRG Oncology trial sets new standard regimen for women with uterine carcinosarcomas
(NRG Oncology) Results from the phase III NRG Oncology clinical trial GOG 0261 comparing paclitaxel plus carboplatin (PC) to paclitaxel plus ifosfamide (PI) in women with stage I-IV, recurrent carcinosarcoma of the uterus or ovary, indicate that the PC combination treatment should be considered a standard of care for this patient population. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 3, 2019 Category: Cancer & Oncology Source Type: news

Rates of Nonendometrioid Uterine Cancer Highest in Blacks Rates of Nonendometrioid Uterine Cancer Highest in Blacks
Rates of uterine cancer are increasing in all women, but rates of an aggressive subtype and uterine cancer mortality are highest among blacks, new research indicates.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 30, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Incidence Rates for Aggressive Uterine Cancers on the Rise
Survival rates lowest for non - Hispanic blacks regardless of stage at diagnosis, histologic subtype (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 29, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Journal, Source Type: news

Incidence Rates for Aggressive Uterine Cancers on the Rise
WEDNESDAY, May 29, 2019 -- Hysterectomy-corrected uterine cancer incidence rates show that nonendometrioid carcinoma rates have been increasing among all women, according to a study published online May 22 in the Journal of Clinical Oncology. Megan... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 29, 2019 Category: Pharmaceuticals Source Type: news

Aggressive Uterine Cancer on the Rise, Especially in Blacks: Study
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 28, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Research, Nutrition, News, Source Type: news

Aggressive Uterine Cancer on the Rise, Especially in Blacks: Study
TUESDAY, May 28, 2019 -- There's been a steep uptick in aggressive uterine cancers among American women, especially black women, since 2000, a new study shows. It also found that black women with these aggressive cancers have lower survival rates... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 28, 2019 Category: General Medicine Source Type: news

Aggressive Uterine Cancer on the Rise, Especially in Blacks: Study
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - May 28, 2019 Category: Cancer & Oncology Source Type: news

Study shows incidence rates of aggressive subtypes of uterine cancer rising
Findings also reveal racial disparities, including higher incidence of these aggressive subtypes and poorer survival among non-Hispanic black women. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 22, 2019 Category: American Health Source Type: news

Study shows incidence rates of aggressive subtypes of uterine cancer rising
(NIH/National Cancer Institute) New findings from a study by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, show that US incidence rates for aggressive subtypes of uterine cancer rose rapidly among women ages 30 to 79 from 2000 to 2015. The findings also reveal racial disparities, including higher incidence of these aggressive subtypes and poorer survival -- irrespective of subtype and cancer stage -- among non-Hispanic black women than among women in other racial/ethnic groups. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 22, 2019 Category: Cancer & Oncology Source Type: news

New Study From Invitae Highlights the Importance of Multigene Genetic Testing for Uterine Cancer Patients
Results from one of the largest datasets in uterine cancer presented at The American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting SAN FRANCISCO, May 3, 2019 -- (Healthcare Sales & Marketing Network) -- Resear... Diagnostics, Oncology Invitae Corp, precision medicine, uterine cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 3, 2019 Category: Pharmaceuticals Source Type: news

FDA To Boston Scientific: Stop Selling Pelvic Mesh Tied To Injuries In Women
WASHINGTON (AP) — U.S. health regulators on Tuesday halted sales of a type of surgical mesh used to repair pelvic conditions in women, following years of patients’ reports of injuries and complications from the implants. The Food and Drug Administration ordered the two remaining makers of the mesh — Boston Scientific and Coloplast — to stop selling it immediately, saying the companies failed to show the mesh is safe for long-term use. Several other major manufacturers, including Johnson & Johnson, previously stopped making the mesh. The FDA action does not apply to surgical mesh used to treat ot...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 16, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Boston Scientific FDA Source Type: news

Women's Wellness: Still need a Pap smear after hysterectomy?
It depends. Pap test, also called a Pap smear, is a routine screening test for early diagnosis of cervical cancer. If you had a partial hysterectomy -- when the uterus is removed but the lower end of the uterus (cervix) remains -- your health care provider will likely recommend continued Pap tests. Similarly, if you [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 4, 2019 Category: Databases & Libraries Source Type: news

SIR: UFE bests myomectomy for fibroid treatment
Uterine fibroid embolization (UFE) is a more effective treatment for fibroids...Read more on AuntMinnie.comRelated Reading: Artificial intelligence for MRI distinguishes uterine cancer from fibroids Study finds low reintervention rate for UAE of fibroids MRgFUS offers less-invasive fibroid fix Further intervention rates vary after fibroid removal MRI helps distinguish fibroids from uterine cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 25, 2019 Category: Radiology Source Type: news

Nigeria: Talcum Powder May Cause Cancer, Experts Warn
[Guardian] Researchers are unanimous that talc or talcum powder can cause lung, ovarian, stomach and endometrial (uterine) cancers. They said talc consisting of asbestos is generally accepted as being able to cause cancer if it is inhaled or/and used regularly in the genital area. Evidence on asbestos-free talc is however less clear. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 22, 2019 Category: African Health Source Type: news

Women's Wellness: Connect with women living with gynecologic cancer
Gynecologic cancers include?cervical cancer, endometriosis, fibroids,?ovarian cancer, pelvic masses,?uterine cancer,?vaginal cancer?and?vulvar cancer. Mayo Clinic Connect is a place where you can meet women living with a gynecologic cancer or caring for someone with gynecologic cancer. You can ask your questions, share your story, or just say hello. "Connect members find connection, support, and information from [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 21, 2019 Category: Databases & Libraries Source Type: news

Infertility in Women Linked to Modestly Elevated Cancer Risk
Overall risk higher for developing cancer; increased risks seen for uterine, ovarian, lung, thyroid cancers (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 15, 2019 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Oncology, Journal, Source Type: news

I Had Lynch Syndrome For 30 Hours
As a genetic counselor, I have been taking the popular home DNA tests on the market. My raw data showed that I have Lynch syndrome, a hereditary cancer syndrome that increases the risk of colorectal, uterine, ovary, and other cancers. Further testing proved that this result was a false positive. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 12, 2019 Category: Pharmaceuticals Authors: Ellen Matloff, Contributor Source Type: news

Obesity-Linked Cancers On the Rise in Young Adults
In the study, the cancer incidence increases were particularly severe in six of the 12 obesity-related cancers: colon, uterine, gallbladder, kidney and pancreas, and multiple myeloma -- a bone marrow cancer. (Source: WebMD Health)
Source: WebMD Health - February 4, 2019 Category: Consumer Health News Source Type: news

Millennials Getting More Obesity-Related Cancers, Study Finds
This study shows the incidence of cancer associated with obesity has been rising dramatically in groups of individuals born in more recent decades,” said MD Anderson Cancer Center’s Dr. George Chang, who was not associated with the analysis. However, Chang warns against overgeneralizing on the basis of an epidemiological study. “The study was not set up to establish causation,” Chang said. “We know there are many factors that are associated with both obesity and cancer, such as lack of exercise and poor diet. How much each of those factors contribute to cancer is less clear.” Obesity is ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 4, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Cancer CNN Millennials Source Type: news

Why we need a BI-RADS-like system for uterine tumors
Does radiology need a scoring system like BI-RADS for tracking uterine tumors?...Read more on AuntMinnie.comRelated Reading: Study shows uterine cancer prevalence after morcellation Comments: 2/4/2019 7:28:08 AMmedphys While a UI-RADS system would be a step in the right direction, there's a worse problem:  some ob/gyn offices use their own ultrasound units, and it's not obvious that any radiologist ever sees the images.  These ob/gyn offices have a financial motivation to NOT refer any patients for ultrasound in a radiology department.   2/4/2019 8:09:38 AMDr. DG from Toronto I am very sorr...
Source: AuntMinnie.com Headlines - February 4, 2019 Category: Radiology Source Type: news

Obesity Tied to Higher Cancer Rates in Younger People
For six of the 12 obesity-related cancers (multiple myeloma, colorectal, uterine, gallbladder, kidney and pancreatic) the risk for disease increased in adults 25 to 49. (Source: NYT Health)
Source: NYT Health - February 4, 2019 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Obesity Weight Cancer Pancreas Multiple Myeloma Colon and Colorectal Cancer Source Type: news